Entasis Therapeutics Holdings Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 27th, 2021 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • New York
Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
